A peptide certificate of analysis is a short document that carries a lot of weight. It is the supplier's statement of what is in a specific vial, measured by specific methods, on a specific date. This guide walks through each section of a typical peptide certificate of analysis, explains what the numbers can and cannot tell you, and uses a BPC-157 lot as a worked example. By the end you should be able to spot a complete CoA, a thin one, and one that does not match the product it came with.
Why the peptide certificate of analysis matters
Synthetic peptides are made by stepwise chemistry, and every step can leave a trace: a sequence missing one residue, a side-chain protecting group that never came off, an oxidized methionine. A structured review of peptide impurities groups these into synthesis-related species (deletions, insertions, diastereomers, protection adducts), degradation products (deamidation, pyroglutamate formation, diketopiperazines) and unwanted counterions such as trifluoroacetate [2]. Any of them can alter an assay readout.
The practical risk is real. When a Belgian group re-analysed a set of commercially synthesized quorum-sensing peptides ordered at 95% or better, only 44% met the requested purity, and one sample's main component had a different structure from the peptide that had been ordered [1]. The authors' conclusion was blunt: relying on the supplier's certificate alone can compromise research, and labs should keep their own QC in place [1]. A CoA is the start of verification, not the end.
The header block: identity of the lot, not the product
The top of a CoA should identify the physical material, not just the catalogue item. Look for:
- Product name and sequence, written out in full with any terminal modifications (for example an N-terminal acetyl or C-terminal amide).
- Molecular formula and theoretical molecular weight, which the mass spectrometry section will be checked against.
- Lot or batch number, which must match the label on the vial in your hand.
- Date of analysis and, ideally, date of manufacture.
- The testing laboratory and a signature or approval line, so the document can be traced to a person and a place.
If the lot number is missing or generic, none of the analytical data below can be tied to your material. Our post on lot numbers and traceability covers why that link matters.
Reading the HPLC purity section
Most CoAs report purity by reversed-phase HPLC with UV detection, usually at 214 to 220 nm where the peptide bond absorbs. The figure is an area percentage: the area of the main peak divided by the total area of all integrated peaks. That makes it a relative measure. Anything that does not absorb at that wavelength, or that elutes outside the gradient window, is invisible to it.
A useful CoA reports more than a single number. Check for the column type (typically a C18, 4.6 x 150 or 250 mm), the mobile phases (commonly water and acetonitrile, each with 0.1% TFA), the gradient, the detection wavelength and the retention time of the main peak. Better still is an attached chromatogram. A clean baseline, a sharp main peak and small, well-resolved impurity peaks are what you want to see. A chromatogram cropped so tightly that only the main peak is visible should raise questions.
Method choice matters more than people assume. Work on cationic peptides showed that the acidic modifier (formic acid versus TFA), the particle size and the column temperature all changed the purity figure reported for the same material [5]. Two labs can quote different purities for one lot without either being wrong. For a deeper look at columns and gradients, see HPLC purity testing for research peptides.
Identity: the mass spectrometry line
HPLC reports what fraction of the sample is one species; it does not say which species. That is the job of mass spectrometry, usually electrospray (ESI-MS) or MALDI-TOF. The CoA should give the theoretical mass and the observed mass. For a small peptide, observed and theoretical values typically agree within about 1 Da on a low-resolution instrument, and within a few parts per million on a high-resolution one.
Watch for which mass is being quoted. ESI spectra of peptides often show multiply charged ions, so a CoA may list an [M+2H]2+ ion at roughly half the molecular weight. That is normal, but the document should say so. A spectrum image showing the observed ions is stronger evidence than a typed number alone. The mass spectrometry identity confirmation article explains how to read those spectra.
A worked example: BPC-157
Here is how the core fields of a CoA for BPC-157 should read, with the values you can check independently:
| Field | What to expect | How to check it |
|---|---|---|
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 residues) | Compare with the published pentadecapeptide sequence |
| Formula | C62H98N16O22 | Sum of residues minus water for each peptide bond |
| Molecular weight | about 1419.5 Da (average); 1418.7 Da (monoisotopic) | Matches the formula |
| Expected ESI ions | [M+H]+ near 1419.7; [M+2H]2+ near 710.4 | Observed mass on the CoA should match one of these |
| HPLC purity | A stated percentage with method details | Look for the chromatogram and retention time |
| Lot number | Matches the vial label | Physical check on receipt |
If the observed mass on a BPC-157 CoA were, say, 1305 Da, that would suggest a species missing a residue (a leucine deletion would drop about 113 Da), and purity would be beside the point.
What a CoA often leaves out
Several properties that affect experiments are rarely printed:
- Peptide content. Lyophilized peptides contain counterions and bound water. Net peptide content, measured by amino acid analysis or nitrogen determination, is commonly 60 to 90% of the gross weight. Purity says nothing about it.
- Counterion identity. Peptides purified with TFA are usually TFA salts. In one study, trifluoroacetate at 10^-8 to 10^-7 M reduced cell numbers in fetal rat osteoblast cultures, and TFA salts of several peptides produced less proliferation than the matching hydrochloride salts [3]. For cell-based work, knowing the salt form is not a detail.
- Water content, residual solvents and endotoxin. Pharmacopoeial monographs for peptide drugs specify these alongside identity, purity and assay [4]. Research-grade CoAs often omit them, so ask if your assay is sensitive.
Red flags on a certificate of analysis
- No lot number, or a lot number that does not match the vial.
- Purity reported without method, wavelength or chromatogram.
- An identical CoA, date and all, reused across different lots.
- Mass data given only as "conforms" with no observed value.
- A chromatogram whose axes or peak table do not match the stated purity.
Our published lab reports show the chromatogram and mass spectrum for each lot so these checks can be made directly.
Key takeaways
- A CoA is lot-specific evidence. Match the lot number before reading anything else.
- HPLC purity is a relative UV area percentage; it depends on the method and cannot confirm identity.
- Mass spectrometry confirms identity. Check the observed mass against the theoretical value, allowing for charge states.
- Purity and peptide content are different quantities; counterions and water account for the gap.
- Independent studies show supplier CoAs are not always accurate, so in-house or third-party verification is good practice.
This article summarizes published research for informational purposes. All Ascent Sciences products are for laboratory research use only and are not for human or animal consumption.
References
- Verbeke F, Wynendaele E, Braet S, et al. Quality evaluation of synthetic quorum sensing peptides used in R&D. J Pharm Anal. 2015;5(3):169-181. PubMed
- D'Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. PubMed
- Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol. 1999;277(5):E779-E783. PubMed
- Vergote V, Burvenich C, Van de Wiele C, et al. Quality specifications for peptide drugs: a regulatory-pharmaceutical approach. J Pept Sci. 2009;15(11):697-710. PubMed
- Stalmans S, Gevaert B, Verbeke F, et al. Quality control of cationic cell-penetrating peptides. J Pharm Biomed Anal. 2015;117:289-297. PubMed
Frequently asked questions
What is the most important number on a peptide certificate of analysis?
There is no single number. HPLC purity gives the share of the UV-absorbing material that is the target peptide, while the mass spectrometry line says whether that main peak is the right molecule. A CoA needs both, tied to the same lot, to be useful.
Is HPLC purity the same as peptide content?
No. HPLC purity is a relative area percentage among UV-absorbing species. Peptide content is the fraction of the vial's total mass that is peptide, after counterions, water and salts are accounted for. A 99% pure lot can still have a peptide content well below 100%.
Why does the counterion matter for cell-culture work?
Synthetic peptides purified with trifluoroacetic acid usually arrive as TFA salts. A 1999 study reported that trifluoroacetate at nanomolar concentrations reduced proliferation in fetal rat osteoblast cultures, so the salt form is worth knowing before an assay.
Should a lab re-test a peptide that already has a CoA?
Many labs do. A 2015 study of synthetic research peptides found that fewer than half met the purity stated on the supplier's paperwork, and the authors recommended in-house quality control as routine practice.
All Ascent Sciences products are for laboratory research use only and are not for human or animal consumption. This article summarizes published research and is not medical advice. See our Research Use Agreement.